Inhibitory effect of progesterone and 20 alpha-hydroxypregn-4-en-3-one on the phytohemagglutinin-induced transformation of human lymphocytes.
D004092:20-alpha-Dihydroprogesterone / Q000494:pharmacology; D000328:Adult; D000735:Androstenedione / Q000494:pharmacology; D003687:Dehydroepiandrosterone / Q000494:pharmacology; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology; D004964:Estriol / Q000494:pharmacology; D004970:Estrone / Q000494:pharmacology; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000494:pharmacology; D037102:Lectins / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D011239:Prednisolone / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology*; D013739:Testosterone / Q000494:pharmacology
D006908:Hydroxyprogesterones; D037102:Lectins; D004092:20-alpha-Dihydroprogesterone; D004970:Estrone; D013739:Testosterone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D011374:Progesterone; D004958:Estradiol; D011239:Prednisolone; D004964:Estriol